Abstract
In today’s absence of a vaccine and impactful treatments, the most effective way to combat the virus is to find and implement mitigation strategies. An invaluable resource in this task is numerical modeling that can reveal key factors in COVID-19 pandemic development. On the other hand, it has become evident that regional infection curves of COVID-19 exhibit complex patterns which often differ from curves predicted by forecasting models. The wide variations in attack rate observed among different social strata suggest that this may be due to social heterogeneity not accounted for by regional models. We investigated this hypothesis by developing and using a new Stochastic Heterogeneous Epidemic Model (SHEM) that focuses on subpopulations that are vulnerable in the sense of having an increased likelihood of spreading infection among themselves. We found that the isolation or embedding of vulnerable sub-clusters in a major population hub generated complex stochastic infection patterns which included multiple peaks and growth periods, an extended plateau, a prolonged tail, or a delayed second wave of infection. Embedded vulnerable groups became hotspots that drove infection despite efforts of the main population to socially distance, while isolated groups suffered delayed but intense infection. Amplification of infection by these hotspots facilitated transmission from one urban area to another, causing the epidemic to hopscotch in a stochastic manner to places it would not otherwise reach, resembling a microcosm of the situation worldwide as of September 2020. Our results suggest that social heterogeneity is a key factor in the formation of complex infection propagation patterns. Thus, the mitigation of vulnerable groups is essential to control the COVID-19 pandemic worldwide. The design of our new model allows it to be applied in future studies of real-world scenarios on any scale, limited only by computing memory and the ability to determine the underlying topology and parameters.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The work was supported by the Intramural Research Program of the National Institute on Aging, National Institute of Health.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This work is purely theoretical using models/simulations and does not use any real human subject data.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Results were updated with additional simulations introducing a vaccination into hotspot populations. A new figure 5 was added. The model code and parameters were updated and the movies were accelerated. The paper text was revised accordingly.
Data Availability
All data is available in the manuscript and supplementary materials.
